Health
RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia – News-Medical.Net
RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced presentation of the positive Phase 2 safety and…
RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced presentation of the positive Phase 2 safety and efficacy data for oral opaganib (Yeliva®, ABC294640) in hospitalized patients with…
Continue Reading
-
Noosa News14 hours agoBrisbane vs Collingwood live blog: Richmond selects Noah Balta as unbeaten Lions prepare for Magpies test
-
Noosa News17 hours agoAustralians tell ABC’s Your Say how they saw the second leaders debate
-
General13 hours agoNT Coalition candidate Lisa Siebert diverges from Jacinta Nampijinpa Price on royal commission call
-
General15 hours agoCanberra man named as doctor accused of rape after suppression order lifted